Both in Pharmaceuticals
Supernus vs Ocular Therapeutix
Over the past year SUPN returned −50.5% and OCUL returned −34.5%; their daily moves had a correlation of 0.15.
SUPN −50.5% OCUL −34.5%Growth of $1, one year, split-adjusted
| Metric | SUPN | OCUL |
|---|---|---|
| Price | $28.21 | $7.14 |
| Market cap | $1.64B | $1.57B |
| Today | +0.21% | +4.69% |
| 1 month | −34.1% | −2.7% |
| 6 months | −45.2% | −26.5% |
| Year to date | −43.2% | −41.2% |
| 1 year | — | −37.4% |
| Revenue growth (YoY) | +18.0% | +0.1% |
| Gross margin | 88.1% | 85.1% |
| Net margin | 9.2% | −584.5% |
| P/E (TTM) | — | — |
| Price / sales | 1.9× | 30.1× |
| Net cash | $359.5M | $525.8M |
| Dividend yield | 28.82% | — |
| Volatility (60d) | 86.1% | 75.4% |
| Short % of float | 7.3% | 15.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).